Page last updated: 2024-11-13
avenacoside b
Description
avenacoside B: from Avena sativa L.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
avenacoside B : A steroid saponin obtained from grain and leaves of oats (Avena sativa) that is nuatigenin in which the hydroxy group at position 26 is converted to its beta-D-glucoside and in which the hydroxy group at position 3 is converted into its methyl alpha-L-rhamnopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranosyl-(1->4)]-beta-D-glucopyranoside derivative. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Flora | Rank | Flora Definition | Family | Family Definition |
Avena | genus | Oats, genus of the family POACEAE.[MeSH] | Poaceae | A large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons). Food grains (EDIBLE GRAIN) come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.[MeSH] |
Avena sativa | species | A plant species of the family POACEAE that is widely cultivated for its EDIBLE GRAIN.[MeSH] | Poaceae | A large family of narrow-leaved herbaceous grasses of the order Cyperales, subclass Commelinidae, class Liliopsida (monocotyledons). Food grains (EDIBLE GRAIN) come from members of this family. RHINITIS, ALLERGIC, SEASONAL can be induced by POLLEN of many of the grasses.[MeSH] |
Cross-References
Synonyms (8)
Synonym |
nuatigenin 3-o-{alpha-l-rhamnopyranosyl-(1->2)-[beta-d-glucopyranosyl-(1->3)-beta-d-glucopyranosyl-(1->4)]-beta-d-glucopyranoside}-26-o-beta-d-glucopyranoside |
C08888 , |
avenacoside b |
(3beta,22s,25s)-3-{[6-deoxy-alpha-l-mannopyranosyl-(1->2)-[beta-d-glucopyranosyl-(1->3)-beta-d-glucopyranosyl-(1->4)]-beta-d-glucopyranosyl]oxy}-22,25-epoxyfurost-5-en-26-yl beta-d-glucopyranoside |
CHEBI:2938 |
nuatigenin 3-o-{alpha-l-rhamnopyranosyl-(1->2)-[beta-d-glucopyranosyl-(1->3)-beta-d-glucopyranosyl-(1->4)]-beta-d-glucopyranoside} 26-o-beta-d-glucopyranoside |
Q27105893 |
CHEMBL4635475 |
Roles (1)
Role | Description |
metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (5)
Class | Description |
hexacyclic triterpenoid | A triterpenoid that consists of a hexacyclic ring system. |
tetrasaccharide derivative | An oligosaccharide derivative that is formally obtained from a tetrasaccharide. |
spiroketal | A cyclic ketal in which the ketal carbon is the only common atom of two rings. |
steroid saponin | Any saponin derived from a hydroxysteroid. |
beta-D-glucoside | Any D-glucoside in which the anomeric centre has beta-configuration. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.56 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (33.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (66.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |